[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPH0394780A - Treating device - Google Patents

Treating device

Info

Publication number
JPH0394780A
JPH0394780A JP1233431A JP23343189A JPH0394780A JP H0394780 A JPH0394780 A JP H0394780A JP 1233431 A JP1233431 A JP 1233431A JP 23343189 A JP23343189 A JP 23343189A JP H0394780 A JPH0394780 A JP H0394780A
Authority
JP
Japan
Prior art keywords
luminous body
chemiluminescent
chemical luminous
semiconductor
electrode layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1233431A
Other languages
Japanese (ja)
Inventor
Kazuhiko Ozeki
大関 和彦
Ryoichi Kono
小納 良一
Isami Hirao
平尾 勇実
Koji Kanbara
神原 浩司
Koichi Kawashima
晃一 川島
Yasuhiro Ueda
康弘 植田
Hiromasa Suzuki
鈴木 博雅
Eiichi Fuse
栄一 布施
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olympus Corp
Original Assignee
Olympus Optical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olympus Optical Co Ltd filed Critical Olympus Optical Co Ltd
Priority to JP1233431A priority Critical patent/JPH0394780A/en
Publication of JPH0394780A publication Critical patent/JPH0394780A/en
Pending legal-status Critical Current

Links

Landscapes

  • Laser Surgery Devices (AREA)
  • Radiation-Therapy Devices (AREA)
  • Surgical Instruments (AREA)

Abstract

PURPOSE:To surely and easily treat a desired section with a simple structure by providing a semiconductor material having a photocatalytic effect in at least a part on the outside surface of a chemical luminous body consisting of a chemical light emitting agent. CONSTITUTION:The chemical luminous body 2 is detained in the malignant tumor, for example, cancer tissue 9, generated on the inner side of the inlet part 8 of the uterus 7 of a patient in the state in which the semiconductor electrode layer 6 applied on the surface of the chemical luminous body 2 is held in contact with the cancer tissue 9 when the chemical luminous body 2 is inserted into the above-mentioned inlet part 8. An oxidation reaction takes place on the semiconductor electrode layer 6 when the chemical luminous body 2 emits light for a specified period of time and the illumination light falls onto the semiconductor electrode layer 6 in such a manner. The cancer tissue 9 is then killed by the photocatalytic effect. The light emission of the chemical luminous body 2 ends upon lapse of the specified period of time. The chemical luminous body 2 is pulled to the outside of the body by holding yarn 3 after the treatment ends.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、生体内に挿入して生体の患部を治療するため
の治療装置に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a treatment device that is inserted into a living body to treat an affected part of the living body.

[従来の技術] 最近では癌などの悪性IIlg4を治療する方法として
光電気化学治療が知られている。これは光励起された半
導体表面が有する強い反応性を、癌細胞の殺細胞効果に
応用したもので、癌細胞を死滅させるに顕著な効果があ
ることが実験により明らかになっている。
[Prior Art] Recently, photoelectrochemical therapy has been known as a method for treating malignant IIlg4 such as cancer. This is an application of the strong reactivity of the photo-excited semiconductor surface to the killing effect on cancer cells, and experiments have shown that it has a remarkable effect on killing cancer cells.

ここで、半導体微粒子の光化学反応の原理について説明
すると、第6図に示すように、ある種の?導体は、光を
当てると光励起により価電子帯の電子が伝導体に励起さ
れ、価電子帯に正孔ができる。この電子と正孔が再結合
しなければ、これらを酸化還元反応に利用できる。すな
わち、伝導体に励起された電子は価電子帯の電子よりバ
ンドギャップ分だけエネルギーが高いため還元力が強く
、価電子帯の正孔は伝導体の空準位よりバンドギャップ
分だけ電子親和力が大きいので酸化能力がある。酸化力
、還元力ともに強い半導体として酸化チタン(以下、T
iO■という)が知られており、このTie2の半導体
微粒子に白金(以下、ptという)を担持すると、Tt
02の光触媒能が著しく増加することも知られている。
Now, to explain the principle of the photochemical reaction of semiconductor particles, as shown in Figure 6, there is a type of photochemical reaction. When a conductor is exposed to light, electrons in the valence band are excited into the conductor by photoexcitation, and holes are created in the valence band. If these electrons and holes do not recombine, they can be used for redox reactions. In other words, electrons excited in a conductor have higher energy than electrons in the valence band by the amount of the band gap, so they have a stronger reducing power, and holes in the valence band have a higher electron affinity than empty levels in the conductor by the amount of the band gap. Because it is large, it has oxidizing ability. Titanium oxide (hereinafter referred to as T) is a semiconductor with strong oxidizing and reducing powers.
iO■) is known, and when platinum (hereinafter referred to as pt) is supported on the semiconductor fine particles of Tie2, Tt
It is also known that the photocatalytic ability of 02 is significantly increased.

ptを含むT i O 2の粉末が溶液に懸濁している
状態の光触媒系は、光化学電池同様、半導体が光励起さ
れることによっていろいろの反応が進行する。この光励
起は半導体のバンドギャップに相当する波長よりも短波
長(TiO2の場合415nm)の光が照射されると起
こり、光励起されたT i O 2表面は非常に強い酸
化力を有し、いろいろ化合物を酸化分解できる。
In a photocatalytic system in which T i O 2 powder containing pt is suspended in a solution, various reactions proceed as a semiconductor is photoexcited, similar to a photochemical cell. This photoexcitation occurs when light with a wavelength shorter than the wavelength corresponding to the band gap of the semiconductor (415 nm in the case of TiO2) is irradiated, and the photoexcited TiO2 surface has a very strong oxidizing power, and it can be oxidized and decomposed.

また、半導体微粒子の粒径が小さい程、反応活性度は大
きく・なる( T i O 2の場合、0.2μm以下
が反応活性度最大)とともに、半導体微粒子の数が多い
程、また光量が大きい程効果が大きい。
In addition, the smaller the particle size of the semiconductor particles, the higher the reaction activity (in the case of TiO2, the maximum reaction activity is 0.2 μm or less), and the larger the number of semiconductor particles, the greater the amount of light. The effect is large.

この半導体が光励起されることによる反応を利用して殺
菌、悪性腫瘍等の死滅させる技術は、例えば特開昭62
−87526号公報、特開昭63−1.77849号公
報において公知であり、特に後者のものは、内視鏡の挿
通チャンネルを通じて治療用ブローブを生体に導入し、
光触媒効果を有する半導体電極と白金電極を癌部位に穿
刺し、前記治療用ブローブの先端面から照射されるレー
ザ光を前記半導体電極の表面に照射するようになってい
る。半導体電極にレーザ光が照射されると、半導体電極
上では酸化反応が起こり、白金電極上では還元反応が起
こる。そして、両電極間には癌部位があることにより、
水分戊分に前記反応が起こり、半導体電極上では酸素が
発生し、白金電極上では水分が発生し、つまり、光触媒
効果が生じることになる。
For example, the technology for sterilizing and killing malignant tumors by utilizing the reaction caused by photoexcitation of semiconductors was developed in Japanese Patent Application Laid-open No. 62
-87526 and Japanese Unexamined Patent Publication No. 63-1.77849, particularly the latter, in which a therapeutic probe is introduced into a living body through an insertion channel of an endoscope.
A semiconductor electrode having a photocatalytic effect and a platinum electrode are punctured into a cancer site, and the surface of the semiconductor electrode is irradiated with laser light emitted from the tip of the therapeutic probe. When the semiconductor electrode is irradiated with laser light, an oxidation reaction occurs on the semiconductor electrode, and a reduction reaction occurs on the platinum electrode. Since there is a cancerous site between the two electrodes,
The reaction occurs when water is removed, and oxygen is generated on the semiconductor electrode and moisture is generated on the platinum electrode, that is, a photocatalytic effect occurs.

[発明が解決しようとする課題] しかしながら、前述のような治療装置は、内視鏡の挿通
チャンネルを通じて治療用ブローブを生体に導入し、光
触媒効果を有する半導体電極と白金電極を癌組織等の目
的部位に穿刺し、治療用プローブの先端面から照射され
るレーザ光を前記半導体電極の表面に照射するようにな
っている。
[Problems to be Solved by the Invention] However, the above-mentioned treatment device introduces a therapeutic probe into a living body through an insertion channel of an endoscope, and uses a semiconductor electrode and a platinum electrode that have a photocatalytic effect to target cancer tissue or the like. The site is punctured, and the surface of the semiconductor electrode is irradiated with laser light emitted from the tip of the therapeutic probe.

したがって、電極と光照射部とが別々であり、径が太く
なって人体における治療部位が限定されるという問題が
ある。
Therefore, there is a problem that the electrode and the light irradiation part are separate, and the diameter becomes large, which limits the treatment area in the human body.

本発明は上記課題に着目してなされたもので、その目的
とするところは、構造的に簡単で、目的部位を確実に、
しかも、簡単に治療できる治療装置を提供することにあ
る。
The present invention has been made with attention to the above-mentioned problems, and its purpose is to have a simple structure, to reliably reach the target area, and to
Moreover, it is an object of the present invention to provide a treatment device that can perform treatment easily.

[課題を解決するための手段および作用コ前記課題を解
決するために本発明の治療装置は、化学的発光剤よりな
る化学発光体の外表面の少なくとも一部に光触媒効果を
有する半導体物質を設けたことにある。
[Means and Effects for Solving the Problems] In order to solve the above problems, the treatment device of the present invention includes a method in which a semiconductor material having a photocatalytic effect is provided on at least a part of the outer surface of a chemiluminescent substance made of a chemiluminescent agent. That's true.

化学発光体から発光する光によって半導体物質が酸化反
応を起こして悪性腫瘍を死滅させる。
The light emitted from the chemiluminescent material causes an oxidation reaction in the semiconductor material, killing the malignant tumor.

[実施例コ 以下、本発明の各実施例を図面に基づいて説明する。[Example code] Hereinafter, each embodiment of the present invention will be described based on the drawings.

第1図および第2図は第1の実施例を示すもので、1は
治療装置である。この治療装置1は体腔内に挿入される
カプセル形状の化学発光体2を有しており、この化学発
光体2には糸3が接続されている。化学発光体2は、可
撓性を有する透光性高分子膜よりなる袋体4とこの袋体
4に充填された化学的発光剤5とから形成されている。
FIGS. 1 and 2 show a first embodiment, where 1 is a treatment device. This treatment device 1 has a capsule-shaped chemiluminescent body 2 inserted into a body cavity, and a thread 3 is connected to this chemiluminescent body 2. The chemiluminescent body 2 is formed from a bag body 4 made of a flexible light-transmitting polymer film and a chemiluminescent agent 5 filled in the bag body 4.

この化学的発光剤5は、例えば、米国のTRYLON・
ASSOCIATES−LTD社製のCyalum (
商品名)であって、Cya l uII1は可撓性の袋
に発光薬剤を収容したもので、袋ごと折って振ると、内
部の発光薬剤が発光して袋全体が発光する。発光時間は
大きさによって異なるが、数分〜数時間程度である。
This chemiluminescent agent 5 is, for example, TRYLON of the United States.
Cyalum manufactured by ASSOCIATES-LTD (
Cya l uII1 (trade name) is a flexible bag containing a luminescent agent. When the bag is folded and shaken, the luminescent agent inside emits light and the entire bag emits light. The light emission time varies depending on the size, but is about several minutes to several hours.

前記化学発光体2の外周面における一部、この?施例に
おいては基端側を残して光触媒効果を有する半導体物質
としてのT i 0 2からなる半導体電極層6が設け
られている。この半導体電極層6は、化学発光体2の表
面にTiO■をコーティングを混入したものである。
A part of the outer peripheral surface of the chemiluminescent body 2, this? In this embodiment, a semiconductor electrode layer 6 made of T i 0 2 as a semiconductor material having a photocatalytic effect is provided except on the base end side. This semiconductor electrode layer 6 is obtained by coating the surface of the chemiluminescent material 2 with TiO2.

そして、この治療装置1の使用に際しては、体外て前記
化学発光体2を折って振る。化学発光体2が振られて内
部の化学的発光剤5が発光すると、袋体4を透光して全
体が発光する。次に、第2図に示すように、化学発光体
2を患者の子宮7の人口部8に挿入する。子宮7の人口
部8に化学発光体2を挿入すると、入口部8の内側に発
生している悪性腫瘍、例えば癌組織9に化学発光体2の
表面にコーティングされた半導体電極層6が癌組織9に
接触した状態に留置される。
When using this treatment device 1, the chemiluminescent material 2 is folded and shaken outside the body. When the chemiluminescent material 2 is shaken and the chemiluminescent agent 5 inside emits light, light passes through the bag 4 and the entire bag emits light. Next, as shown in FIG. 2, the chemiluminescent material 2 is inserted into the artificial part 8 of the patient's uterus 7. When the chemiluminescent material 2 is inserted into the artificial part 8 of the uterus 7, the semiconductor electrode layer 6 coated on the surface of the chemiluminescent material 2 is applied to a malignant tumor, for example, a cancerous tissue 9, which has developed inside the entrance part 8. 9 was placed in contact with the patient.

このようにして化学発光体2が一定時間発光して半導体
電極層6に照明光が当たると、半導体電極層6上では酸
化反応が起こり、光触媒効果によって癌紹織9を死滅さ
せることができる。一定時間経過後、化学発光体2の発
光が終わり、治療が終了したのちは、糸3を持って化学
発光体2を体外に引抜くことができる。
In this manner, when the chemiluminescent body 2 emits light for a certain period of time and illumination light hits the semiconductor electrode layer 6, an oxidation reaction occurs on the semiconductor electrode layer 6, and the cancerous tissue 9 can be killed by the photocatalytic effect. After a certain period of time has elapsed, the chemiluminescent material 2 stops emitting light, and after the treatment is complete, the chemiluminescent material 2 can be pulled out of the body by holding the thread 3.

第3図は第2の実施例を示すもので、この治療装置1は
体腔内に挿入されるカプセル形状の化学発光体2に弾性
ロッド10を設けたものである。
FIG. 3 shows a second embodiment, and this treatment device 1 includes an elastic rod 10 attached to a capsule-shaped chemiluminescent body 2 inserted into a body cavity.

化学発光体2は、基本的に第1の実施例と同一であり、
可撓性を有する透光性高分子膜よりなる袋体4に化学的
発光剤5が収容されている。そして、この化学発光体2
の全周に光触媒効果を有する半導体物質としてのTie
2からなる半導体電極層6が設けられている。
The chemiluminescent body 2 is basically the same as the first embodiment,
A chemiluminescent agent 5 is housed in a bag 4 made of a flexible, transparent polymer film. And this chemiluminescent body 2
Tie as a semiconductor material that has a photocatalytic effect all around the
A semiconductor electrode layer 6 consisting of 2 is provided.

したがって、生体の食道11に発生した癌組織9の場合
には、体外で前記化学発光体2を折って振る。化学発光
体2が振られて内部の化学的発光剤5が発光すると、袋
体4を透光して全体が発光する。そこで、弾性ロッド1
0を持って口腔12から食道11に挿入し、弾性ロツド
10の進退によって化学発光体2を癌組織9の位置に導
く。また治療が終了した後、弾性ロッド10を持って化
学発光体2を食道11から抜き取ることができる。
Therefore, in the case of cancerous tissue 9 that has developed in the esophagus 11 of a living body, the chemiluminescent material 2 is broken and shaken outside the body. When the chemiluminescent material 2 is shaken and the chemiluminescent agent 5 inside emits light, light passes through the bag 4 and the entire bag emits light. Therefore, elastic rod 1
0 is inserted into the esophagus 11 through the oral cavity 12, and the chemiluminescent material 2 is guided to the position of the cancerous tissue 9 by advancing and retracting the elastic rod 10. Further, after the treatment is finished, the chemiluminescent material 2 can be removed from the esophagus 11 by holding the elastic rod 10.

第4図および第5図は第3の実施例を示すもので、この
治療装置1は体腔内に押入されるカプセル形状の化学発
光体2に挿入ガイドロツドl3を設けたものである。化
学発光体2は、基本的に第1の実施例と同一であり、可
撓性を有する透光性高分子膜よりなる袋体4に化学的発
光剤5が収容されている。そして、この化学発光体2の
全周に光触媒効果を有する半導体物質としてのT i 
O 2からなる半導体電極層6が設けられている。
FIGS. 4 and 5 show a third embodiment, in which the treatment device 1 is provided with an insertion guide rod 13 on a capsule-shaped chemiluminescent body 2 to be inserted into a body cavity. The chemiluminescent material 2 is basically the same as that in the first embodiment, and a chemiluminescent agent 5 is housed in a bag body 4 made of a flexible light-transmitting polymer film. Then, Ti as a semiconductor material having a photocatalytic effect is formed around the entire circumference of this chemiluminescent body 2.
A semiconductor electrode layer 6 made of O 2 is provided.

したがって、前立腺14に発生した癌組織9の場合には
、尿道15に硬性シース16を挿入し、挿入ガイドロッ
ド13を持って前記硬性シース16を案内として前記化
学発光体2を前立腺14に挿入する。すなわち、化学発
光体2を折って振り、内部の化学的発光剤5が発光した
のち、挿入ガイド性ロッド13を持って化学発光体2を
硬性シース16に挿入し、さらに、挿入ガイドロッド1
3を前進させて化学発光体2を癌組織9の位置に導く。
Therefore, in the case of cancerous tissue 9 that has developed in the prostate 14, the hard sheath 16 is inserted into the urethra 15, and the chemiluminescent material 2 is inserted into the prostate 14 by holding the insertion guide rod 13 and using the hard sheath 16 as a guide. . That is, after the chemiluminescent material 2 is folded and shaken so that the chemiluminescent agent 5 inside emits light, the chemiluminescent material 2 is inserted into the rigid sheath 16 by holding the insertion guide rod 13, and then the chemiluminescent material 2 is inserted into the rigid sheath 16 using the insertion guide rod 1.
3 is advanced to guide the chemiluminescent body 2 to the position of the cancerous tissue 9.

また治療が終了した後、挿入ガイドロッド13を持って
化学発光体2を前立腺14から抜き取ることができる。
Further, after the treatment is completed, the chemiluminescent material 2 can be extracted from the prostate 14 by holding the insertion guide rod 13.

尚、硬性シース16に代って硬性尿道鏡のガイドシース
と共用してもよい。
Note that the rigid sheath 16 may be replaced with a guide sheath of a rigid urethroscope.

なお、前記第2、第3の実施例においては、半導体電極
層10はTie2単体であるが、Tie2にptを担持
してもよい。Tie2にptを担持すると、Tie2の
光触媒能が著しく増加し、癌組織9を効果的に死滅させ
ることができる。
In the second and third embodiments, the semiconductor electrode layer 10 is made of Tie2 alone, but Tie2 may carry pt. When Tie2 carries pt, the photocatalytic ability of Tie2 increases significantly, and cancer tissue 9 can be effectively killed.

〔発明の効果コ 以上説明したように本発明によれば、化学的発光剤より
なる化学発光体の外表面の少なくとも一部に光触媒効果
を有する半導体物質を設け、化学発光体から発光する光
によって半導体物質が酸化反応を起こして悪性腫瘍を死
滅させることができ、構造的に簡単で目的部位を確実に
治療できる治療装置を提供できる。
[Effects of the Invention] As explained above, according to the present invention, a semiconductor substance having a photocatalytic effect is provided on at least a part of the outer surface of a chemiluminescent body made of a chemiluminescent agent, and light emitted from the chemiluminescent substance It is possible to provide a treatment device that can kill malignant tumors by causing an oxidation reaction in the semiconductor material, has a simple structure, and can reliably treat the target site.

【図面の簡単な説明】[Brief explanation of drawings]

第1図および第2図は本発明の第1の実施例を示し、第
1図は治療装置の断面図、第2図はその使用状態の断面
図、第3図は本発明の第2の実施置の断面図、第5図は
その使用状態の断面図、第6図は先電気化学反応プロセ
スを示す図である。 1・・・治療装置、2・・・化学発光体、6・・・半導
体電極層。
1 and 2 show a first embodiment of the present invention, FIG. 1 is a sectional view of the treatment device, FIG. 2 is a sectional view of the device in use, and FIG. 3 is a second embodiment of the present invention. FIG. 5 is a sectional view of the actual device, FIG. 5 is a sectional view of its usage state, and FIG. 6 is a diagram showing the electrochemical reaction process. DESCRIPTION OF SYMBOLS 1... Treatment device, 2... Chemiluminescent material, 6... Semiconductor electrode layer.

Claims (1)

【特許請求の範囲】[Claims] 化学的発光剤よりなる化学発光体の外表面の少なくとも
一部に光触媒効果を有する半導体物質を設けたことを特
徴とする治療装置。
A treatment device characterized in that a semiconductor material having a photocatalytic effect is provided on at least a part of the outer surface of a chemiluminescent body made of a chemiluminescent agent.
JP1233431A 1989-09-08 1989-09-08 Treating device Pending JPH0394780A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1233431A JPH0394780A (en) 1989-09-08 1989-09-08 Treating device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1233431A JPH0394780A (en) 1989-09-08 1989-09-08 Treating device

Publications (1)

Publication Number Publication Date
JPH0394780A true JPH0394780A (en) 1991-04-19

Family

ID=16954935

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1233431A Pending JPH0394780A (en) 1989-09-08 1989-09-08 Treating device

Country Status (1)

Country Link
JP (1) JPH0394780A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009523549A (en) * 2006-01-18 2009-06-25 ライト サイエンシーズ オンコロジー, インコーポレイテッド Method and apparatus for photoactivated drug therapy

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009523549A (en) * 2006-01-18 2009-06-25 ライト サイエンシーズ オンコロジー, インコーポレイテッド Method and apparatus for photoactivated drug therapy
JP2014087682A (en) * 2006-01-18 2014-05-15 Light Sciences Oncology Inc Method and apparatus for photoactivated drug therapy

Similar Documents

Publication Publication Date Title
RU2420330C2 (en) Photosensitiser activation method
US7107996B2 (en) Apparatus and method for treating atherosclerotic vascular disease through light sterilization
JP3648555B2 (en) Improved phototherapy device for irradiating a columnar environment
RU2108122C1 (en) Method and device for physiotherapeutic irradiation with light
US20010034503A1 (en) Device for directly delivering an active substance within a cell tissue, means for implanting said device and appliances for injecting active substance into said device
US6463124B1 (en) Miniature energy transducer for emitting x-ray radiation including schottky cathode
JPH0341194B2 (en)
JP3170313U (en) Device for photodynamic therapy of biological tissue
US9474769B2 (en) Methods of treating cancers
JPH0394780A (en) Treating device
KR20180118564A (en) Plasma Treatment Water with Anticancer Activiyt and Manufacturing Method Thereof
US20160325112A1 (en) Photon upconverting implantable medical devices
JP2008229335A (en) Agent for photodynamic therapy comprising porous silicon and method of quantitative measurement of active oxygen produced therefrom
JP2011161222A (en) Optical wound treatment device
US6911771B1 (en) Fluorescent film with luminescent particles
JPH0394762A (en) Tubular member for living body
JPH03176075A (en) Apparatus for releasing medicine gradually
JPH0394759A (en) Treating implement sterilizing system for endoscope
JPH0394777A (en) Medical treatment device
RU2595792C2 (en) Device for use in antimicrobial photodynamic therapy
KR100836167B1 (en) Agent for photodynamic therapy containing porous silicon
JPH0394778A (en) Medical treatment device
CN1836729B (en) Target antibody compound for killing tumour cell and its preparation method
KR100564897B1 (en) Photodynamic Therapy using Photosensitizer and Chemical Light
CN114533870B (en) Application of silica coated perovskite quantum dot in preparation of drugs for photodynamic treatment of tumors